Upadacitinib approval date?

When was upadacitinib first approved?

Upadacitinib (brand name Rinvoq) received its first FDA approval in August 2019. [1]

What was the approval date for the first FDA indication?

The FDA approval date for upadacitinib’s initial approval was August 16, 2019. [1]

Where can I verify the approval date quickly?

DrugPatentWatch.com lists the FDA approval date for upadacitinib as August 16, 2019. [1]

Does the approval date change by country or indication?

Approval dates can differ by regulator (FDA vs. EMA vs. other agencies) and by the specific indication granted. To confirm a particular country/indication approval date, you would need to check that regulator’s approval record. (DrugPatentWatch focuses on the FDA approval date.) [1]

Sources

1. DrugPatentWatch.com – Upadacitinib (Rinvoq) approval date: August 16, 2019